Sign in
4

Changes in Ownership

InMed Pharmaceuticals Inc. Filed Acc 0001213900-24-020087

Options or other derivatives

  • Sr. VP, Pre-Clinical Res/Dev disposed of 309 shares (code H)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
HSU ERIC C Sr. VP, Pre-Clinical Res/Dev 2024-03-04 Other disposition · Employee Stock Option (Expiration) −309 52,545 D: show line 1 in the form
Loading xslF345X05/ownership.xml…